BillionToOne, Inc. (BLLN)
NASDAQ: BLLN · Real-Time Price · USD
79.36
-3.60 (-4.34%)
At close: Apr 2, 2026, 4:00 PM EDT
79.40
+0.04 (0.05%)
After-hours: Apr 2, 2026, 4:49 PM EDT
BillionToOne Revenue
In the year 2025, BillionToOne had annual revenue of $305.11M with 99.97% growth. BillionToOne had revenue of $96.05M in the quarter ending December 31, 2025, with 113.09% growth.
Revenue (ttm)
$305.11M
Revenue Growth
+99.97%
P/S Ratio
11.96
Revenue / Employee
$427,927
Employees
713
Market Cap
3.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 305.11M | 152.53M | 99.97% |
| Dec 31, 2024 | 152.58M | 80.85M | 112.72% |
| Dec 31, 2023 | 71.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLLN News
- 1 day ago - BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology - PRNewsWire
- 27 days ago - BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BillionToOne: Delivering And Lagging At The Same Time - Seeking Alpha
- 4 weeks ago - BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewsWire
- 6 weeks ago - BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 7 weeks ago - BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PRNewsWire
- 7 weeks ago - BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - PRNewsWire
- 2 months ago - BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare - PRNewsWire